Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 17Unknown 13Completed 11Not yet recruiting 6Active not recruiting 2Withdrawn 1Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 12Thoracic 10Gastrointestinal 7Gynecologic 6Sarcoma 3Genitourinary 3Dermatologic 3CNS 3Tumor-Agnostic 2Other hematologic neoplasm 2Head & Neck 2Endocrine 2Other solid neoplasm 1Other 1Myeloid 1Lymphoid 1

Conditions

Head and Neck Neoplasms 2Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 66Cisplatin 55Radiotherapy, Intensity-Modulated 28Carboplatin 27Nivolumab 26Paclitaxel 21Magnetic Resonance Spectroscopy 21Radiotherapy 20Cetuximab 16Specimen Handling 15Docetaxel 15Radiation 14Gemcitabine 13Fluorouracil 12Biopsy 12durvalumab 11Platinum 11Taxes 10Drug Therapy 101,2-diaminocyclohexaneplatinum II citrate 10Surveys and Questionnaires 9Capecitabine 9trametinib 8tislelizumab 6lenvatinib 6dabrafenib 6cemiplimab 6atezolizumab 6Radiosurgery 6Ipilimumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Blood Specimen Collection × Head & Neck × Clear all
NCT02597738 2026-05-29

A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine

University of Arkansas

Phase NA Active not recruiting
330 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

NCT05091190 2025-09-11

MADMAS

Hospices Civils de Lyon

Phase NA Active not recruiting
75 enrolled
Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡